ASC Therapeutics “Advanced Genome Editing, Gene & Cell Therapy Platforms in the US and China” won the first prize
ASC Therapeutics “Advanced Genome Editing, Gene & Cell Therapy Platforms in the US and China” won the first prize of the “2021 Fifth Forum For New Drug R&D And Bio-Pharma Projects Roadshow” held on June 24, 2021 in Nanjing Biomedical Valley. Our CEO Ruhong Jiang, PhD, described our three platforms for second-generation gene therapy, CRISPR … Read more